Web application security solution Signal Sciences has secured $35m in its Series C which will aid its growth efforts.
Lead Edge Capital served as the lead investor to the round, while previous backers CRV, Index Ventures, Harrison Metal and OATV all made contributions to the round. As part of the deal, Lead Edge Capital operating partner Lorrie Norrington will join the Signal Sciences board of directors.
Signal Sciences is a web security platform which provides organisations with technology to automatically block cyberthreats. Its web application firewalls and runtime application self-protection solutions give protections from real threats and attacks and can also integrate with other DevOps tools.
Through the new line of funding, the company will look to grow its market expansion efforts and the product development to meet its customer demand for its web application firewalls and runtime application self-protection solutions.
Lead Edge Capital operating partner Lorrie Norrington said, for. “It’s impressive to see Signal Sciences transform the applications security market. The skyrocketing numbers in the web app security market shows the urgent need for better protection in today’s dynamic threat landscape, and Signal Sciences has set a new standard with automation and integrated technology that excels at digital speed and enterprise scale.
“This is what market-changing technology looks like, and it’s providing the protection for business-critical apps that companies need today. We’re thrilled at the opportunity Signal Sciences presents and are excited to see strong innovation in its next-gen product.”
Last year, Index Ventures raised $1.65bn through two new fundraises. It secured $650m for its ninth venture fund and $1bn for its fourth growth vehicle.
The firm recently led the $30m Series B round of Mimiro, formerly ComplyAdvantage, to support the company with accelerating its development and support global operations expansion.
Copyright © 2018 RegTech Analyst
